| Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic JP Rogers, E Chesney, D Oliver, TA Pollak, P McGuire, P Fusar-Poli, ... The Lancet Psychiatry 7 (7), 611-627, 2020 | 3110 | 2020 |
| What causes psychosis? An umbrella review of risk and protective factors J Radua, V Ramella‐Cravaro, JPA Ioannidis, A Reichenberg, ... World psychiatry 17 (1), 49-66, 2018 | 659 | 2018 |
| Deconstructing vulnerability for psychosis: meta-analysis of environmental risk factors for psychosis in subjects at ultra high-risk P Fusar-Poli, M Tantardini, S De Simone, V Ramella-Cravaro, D Oliver, ... European Psychiatry 40, 65-75, 2017 | 394 | 2017 |
| At risk or not at risk? A meta‐analysis of the prognostic accuracy of psychometric interviews for psychosis prediction P Fusar‐Poli, M Cappucciati, G Rutigliano, F Schultze‐Lutter, I Bonoldi, ... World Psychiatry 14 (3), 322-332, 2015 | 310 | 2015 |
| Prenatal and perinatal risk and protective factors for psychosis: a systematic review and meta-analysis C Davies, G Segre, A Estradé, J Radua, A De Micheli, U Provenzani, ... The Lancet Psychiatry 7 (5), 399-410, 2020 | 300 | 2020 |
| Adverse effects of cannabidiol: a systematic review and meta-analysis of randomized clinical trials E Chesney, D Oliver, A Green, S Sovi, J Wilson, A Englund, TP Freeman, ... Neuropsychopharmacology 45 (11), 1799-1806, 2020 | 277 | 2020 |
| Implementing precision psychiatry: a systematic review of individualized prediction models for clinical practice G Salazar de Pablo, E Studerus, J Vaquerizo-Serrano, J Irving, A Catalan, ... Schizophrenia bulletin 47 (2), 284-297, 2021 | 194 | 2021 |
| Neurocognitive functioning in individuals at clinical high risk for psychosis: a systematic review and meta-analysis A Catalan, GS De Pablo, C Aymerich, S Damiani, V Sordi, J Radua, ... JAMA psychiatry 78 (8), 859-867, 2021 | 184 | 2021 |
| What causes the onset of psychosis in individuals at clinical high risk? A meta-analysis of risk and protective factors D Oliver, TJ Reilly, O Baccaredda Boy, N Petros, C Davies, S Borgwardt, ... Schizophrenia bulletin 46 (1), 110-120, 2020 | 181 | 2020 |
| Can we reduce the duration of untreated psychosis? A systematic review and meta-analysis of controlled interventional studies D Oliver, C Davies, G Crossland, S Lim, G Gifford, P McGuire, ... Schizophrenia bulletin 44 (6), 1362-1372, 2018 | 132 | 2018 |
| Universal and selective interventions to promote good mental health in young people: systematic review and meta-analysis GS de Pablo, A De Micheli, DH Nieman, CU Correll, LV Kessing, ... European Neuropsychopharmacology 41, 28-39, 2020 | 117 | 2020 |
| Transdiagnostic risk calculator for the automatic detection of individuals at risk and the prediction of psychosis: second replication in an independent national health service … P Fusar-Poli, N Werbeloff, G Rutigliano, D Oliver, C Davies, D Stahl, ... Schizophrenia Bulletin 45 (3), 562-570, 2019 | 109 | 2019 |
| Are you on my wavelength? Interpersonal coordination in dyadic conversations J Hale, JA Ward, F Buccheri, D Oliver, AFC Hamilton Journal of nonverbal behavior 44, 63-83, 2020 | 97 | 2020 |
| Suicide, self-harm and thoughts of suicide or self-harm in infectious disease epidemics: a systematic review and meta-analysis JP Rogers, E Chesney, D Oliver, N Begum, A Saini, S Wang, P McGuire, ... Epidemiology and psychiatric sciences 30, e32, 2021 | 91* | 2021 |
| Worldwide implementation of clinical services for the prevention of psychosis: the IEPA early intervention in mental health survey M Kotlicka‐Antczak, M Podgórski, D Oliver, NP Maric, L Valmaggia, ... Early intervention in psychiatry 14 (6), 741-750, 2020 | 86 | 2020 |
| Using natural language processing on electronic health records to enhance detection and prediction of psychosis risk J Irving, R Patel, D Oliver, C Colling, M Pritchard, M Broadbent, H Baldwin, ... Schizophrenia bulletin 47 (2), 405-414, 2021 | 78 | 2021 |
| Does cannabidiol make cannabis safer? A randomised, double-blind, cross-over trial of cannabis with four different CBD: THC ratios A Englund, D Oliver, E Chesney, L Chester, J Wilson, S Sovi, A De Micheli, ... Neuropsychopharmacology 48 (6), 869-876, 2023 | 77 | 2023 |
| Global population attributable fraction of potentially modifiable risk factors for mental disorders: a meta-umbrella systematic review E Dragioti, J Radua, M Solmi, C Arango, D Oliver, S Cortese, PB Jones, ... Molecular Psychiatry 27 (8), 3510-3519, 2022 | 76 | 2022 |
| Impact of mental disorders on clinical outcomes of physical diseases: an umbrella review assessing population attributable fraction and generalized impact fraction E Dragioti, J Radua, M Solmi, CJ Gosling, D Oliver, F Lascialfari, ... World Psychiatry 22 (1), 86-104, 2023 | 75 | 2023 |
| Psychosis polyrisk score (PPS) for the detection of individuals at-risk and the prediction of their outcomes D Oliver, J Radua, A Reichenberg, R Uher, P Fusar-Poli Frontiers in psychiatry 10, 174, 2019 | 66 | 2019 |
Fusar-Poli PaoloPrimary: King's College London, UK; Secondary: University of Pavia, ItalyVerified email at kcl.ac.uk
